倒计时一周!第三届“抗体药物研发与质量分析”网络会议召开在即
p style="text-indent: 2em margin-top: 10px margin-bottom: 10px line-height: 1.5em "抗体药物是现代生物医药产业的主力军,目前占全球生物药物市场的50%,是生物医药产业增长最快的细分领域,预计到2025年全球抗体药物的年销售会超过3000亿美金;我国抗体药物产业起步晚,近两年在抗体药物研发方面速度加快,但在抗体结构设计、新药临床前研究与安全评价、工艺和质量稳定性等方面仍存在诸多挑战,这也意味着中国抗体药物产业有着巨大的发展空间,蕴含着丰富的机会。/pp style="text-indent: 2em margin-top: 10px margin-bottom: 10px line-height: 1.5em "为促进我国抗体药物产业持续快速发展,仪器信息网将于strong2020年9月10日-9月11日/strong举办a href="https://www.instrument.com.cn/webinar/meetings/Antibodydrugs/" target="_blank"“抗体药物研发生产与质量控制”/a主题网络研讨会,会议设有“抗体药物研究进展”、“抗体药物质量分析技术”2个专场,共邀请20位业内专家做精彩报告,为广大用户搭建一个即时、高效的交流和学习的平台。/pp style="text-align: center"a href="https://www.instrument.com.cn/webinar/meetings/Antibodydrugs/" target="_blank"img style="max-width: 100% max-height: 100% width: 468px height: 238px " src="https://img1.17img.cn/17img/images/202009/uepic/2ef6718c-8cf8-44c4-af22-3d746e2312be.jpg" title="锘挎姉浣_69035020200729.jpg" alt="锘挎姉浣_69035020200729.jpg" width="468" height="238" border="0" vspace="0"//a/pp style="text-align: center "点击图片报名参会br//pp style="text-align: center "strong会议日程/strong/ptable border="0" cellpadding="0" cellspacing="0" width="679" height="1000" style="border-collapse: collapse width: 648px "colgroupcol width="110" style="width:82.50pt "/col width="466" style="width:349.50pt "/col width="330" style="width:247.50pt "//colgrouptbodytr height="40" style="height:30.00pt " class="firstRow"td colspan="3" class="et3" height="30" width="679" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"strong2020/9/10 抗体药物研究进展/strong/td/trtr height="40" style="height:30.00pt "td class="et6" height="30" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"strong时间/strong/tdtd class="et7" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"strong报告主题/strong/tdtd class="et7" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"strong报告嘉宾/strong/td/trtr height="40" style="height:30.00pt "td class="et8" height="30" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "09:00--09:30/span/tdtd class="et8" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "抗体药物研发的科学探索与质量控制/span/tdtd class="et9" width="247" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "李玉玲br/(浙江健新原力制药有限公司CEO)/span/td/trtr height="40" style="height:30.00pt "td class="et8" height="30" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "09:30--10:00/span/tdtd class="et8" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "分子互作技术在抗体药研发与质控中的应用/span/tdtd class="et9" width="247" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "张睿br/(Cytiva(原GE医疗生命科学事业部)分子互作产品专家)/span/td/trtr height="40" style="height:30.00pt "td class="et8" height="30" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "10:00--10:30/span/tdtd class="et9" width="349" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "创新生物药候选分子的评价和筛选不可缺失的重要环节和指标-商业化产品的适应性Developability/span/tdtd class="et9" width="247" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "杨晓明br/(杭州奕安济世CDMO业务总经理)/span/td/trtr height="40" style="height:30.00pt "td class="et8" height="30" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "10:30--11:00/span/tdtd class="et8" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "默克Supelco液相色谱柱技术在单克隆抗体药物分析方面的应用/span/tdtd class="et8" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "田海玉(默克生命科学产品经理)/span/td/trtr height="40" style="height:30.00pt "td class="et8" height="30" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "11:00--11:30/span/tdtd class="et8" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "治疗性GPCR抗体/span/tdtd class="et9" width="247" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "张成br/(鸿运华宁(杭州)生物医药首席科学官)/span/td/trtr height="40" style="height:30.00pt "td class="et8" height="30" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "11:30--13:30/span/tdtd colspan="2" class="et10" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "strong午休/strong/span/td/trtr height="40" style="height:30.00pt "td class="et8" height="30" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "13:30--14:00/span/tdtd class="et8" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "新冠病毒ADE与抗体药去ADCC/ADCP技术平台/span/tdtd class="et9" width="247" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "孙乐br/(京天成生物总经理)/span/td/trtr height="40" style="height:30.00pt "td class="et8" height="30" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "14:00--14:30/span/tdtd class="et8" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "色谱分析新技术加速推进单克隆抗体药物研发/span/tdtd class="et9" width="247" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "刘晓达br/(赛默飞世尔科技(中国)应用顾问)/span/td/trtr height="40" style="height:30.00pt "td class="et8" height="30" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "14:30--15:00/span/tdtd class="et8" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "抗感染病性疾病单克隆中和抗体筛选及应用/span/tdtd class="et9" width="247" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "严景华br/(中国科学院微生物研究所研究员)/span/td/trtr height="40" style="height:30.00pt "td class="et8" height="30" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "15:00--15:30/span/tdtd class="et8" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "不同类型流式细胞仪在抗体药物研发与质控中的创新应用/span/tdtd class="et9" width="247" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "常青br/(Luminex公司中国区市场经理)/span/td/trtr height="40" style="height:30.00pt "td class="et8" height="30" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "16:00--16:30/span/tdtd class="et8" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "抗体药物研发靶点选择/span/tdtd class="et8" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "张娟(中国药科大学教授)/span/td/trtr height="40" style="height:30.00pt "td colspan="3" class="et12" height="30" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "strong2020/9/11 抗体药物质量分析技术/strong/span/td/trtr height="40" style="height:30.00pt "td class="et8" height="30" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "09:00--09:30/span/tdtd class="et9" width="349" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "QbD approach to analytical method development and optimization/span/tdtd class="et9" width="247" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "施立明br/(杭州奕安济世生物药业有限公司分析科学、质量控制、工艺与产品开发运营副总裁)/span/td/trtr height="40" style="height:30.00pt "td class="et8" height="30" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "09:30--10:00/span/tdtd class="et8" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "Qsep毛细管电泳仪和INB-D200生物标志物分析仪在抗体药物/span/tdtd class="et9" width="247" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "吴姗br/(杭州厚泽生物)/span/td/trtr height="40" style="height:30.00pt "td class="et8" height="30" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "10:00--10:30/span/tdtd class="et8" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "抗体产品杂质鉴定和表征技术探讨及运用/span/tdtd class="et8" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "谢红伟(生物药分析表征和抗体产品开发专家)/span/td/trtr height="40" style="height:30.00pt "td class="et8" height="30" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "10:30--11:00/span/tdtd class="et8" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "岛津质谱在抗体药物质量控制中的应用/span/tdtd class="et9" width="247" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "邵锴br/(岛津)/span/td/trtr height="40" style="height:30.00pt "td class="et8" height="30" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "11:00--11:30/span/tdtd class="et8" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "毛细管电泳与抗体药物分析/span/tdtd class="et9" width="247" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "屈锋br/(北京理工大学教授)/span/td/trtr height="40" style="height:30.00pt "td class="et8" height="30" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "12:00--14:00/span/tdtd colspan="2" class="et10" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "strong午休/strong/span/td/trtr height="40" style="height:30.00pt "td class="et8" height="30" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "13:30--14:00/span/tdtd class="et8" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "蛋白药物的糖基化修饰及表征研究/span/tdtd class="et9" width="247" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "易继祖br/(友芝友生物副总裁)/span/td/trtr height="40" style="height:30.00pt "td class="et8" height="30" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "14:00--14:30/span/tdtd class="et8" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "抗体药物生产中细胞生长状态和抗体制剂的质控方法/span/tdtd class="et9" width="247" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "姚金龙br/(贝克曼库尔特生命科学细胞活力分析应用专家)/span/td/trtr height="40" style="height:30.00pt "td class="et8" height="30" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "14:30--15:00/span/tdtd class="et8" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "单克隆抗体药物整合质谱分析技术研究/span/tdtd class="et9" width="247" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "张金兰br/(中国医学科学院药物研究所研究员)/span/td/trtr height="40" style="height:30.00pt "td class="et8" height="30" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "15:00--15:30/span/tdtd class="et8" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "微量真实粘度技术在生物医药中的应用/span/tdtd class="et9" width="247" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "刘兵br/(锐欧森锐欧森中国业务总经理)/span/td/trtr height="40" style="height:30.00pt "td class="et8" height="30" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "15:30--16:00/span/tdtd class="et8" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "高效液相色谱法评估单抗药物的关键质量属性(CQA)/span/tdtd class="et9" width="247" x:str="" style="border: 1px solid rgb(0, 0, 0) padding: 5px " align="center" valign="middle"span style="font-size: 14px "李国荣br/(苏州美极医疗科技有限公司总裁)/span/td/tr/tbody/tablep style="text-align: left text-indent: 2em "span style="color: rgb(192, 0, 0) "strong点击链接报名参会:/strong/spana href="https://www.instrument.com.cn/webinar/meetings/Antibodydrugs/" target="_blank" style="color: rgb(192, 0, 0) text-decoration: underline "span style="color: rgb(192, 0, 0) "stronghttps://www.instrument.com.cn/webinar/meetings/Antibodydrugs//strong/span/a/pp style="text-indent: 2em text-align: left "加入抗体药物交流群,及时了解会议相关信息!/pp style="text-align: center "img style="max-width: 100% max-height: 100% width: 256px height: 258px " src="https://img1.17img.cn/17img/images/202009/uepic/b2d7cf61-dc4d-4fea-8cb6-b674103680f3.jpg" title="抗体药物会议.png" alt="抗体药物会议.png" width="256" height="258"//pp style="text-align: center "抗体药物交流群/p